View ValuationEBM Technologies 将来の成長Future 基準チェック /06現在、 EBM Technologiesの成長と収益を予測するのに十分なアナリストの調査がありません。主要情報n/a収益成長率n/aEPS成長率Healthcare Services 収益成長41.4%収益成長率n/a将来の株主資本利益率n/aアナリストカバレッジNone最終更新日n/a今後の成長に関する最新情報更新なしすべての更新を表示Recent updatesReported Earnings • May 12First quarter 2026 earnings releasedFirst quarter 2026 results: Revenue: NT$51.6m (up 122% from 1Q 2025). Net loss: NT$1.53m (loss narrowed 94% from 1Q 2025). Over the last 3 years on average, earnings per share has increased by 105% per year but the company’s share price has fallen by 5% per year, which means it is significantly lagging earnings.Reported Earnings • Mar 13Full year 2025 earnings released: EPS: NT$0.24 (vs NT$0.067 in FY 2024)Full year 2025 results: EPS: NT$0.24 (up from NT$0.067 in FY 2024). Revenue: NT$253.1m (down 9.9% from FY 2024). Net income: NT$7.80m (up 264% from FY 2024). Profit margin: 3.1% (up from 0.8% in FY 2024). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 78% per year but the company’s share price has remained flat, which means it is significantly lagging earnings.New Risk • Mar 13New major risk - Earnings qualityThe company has a high level of non-cash earnings. Accrual ratio: 41% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (41% accrual ratio). Minor Risk Market cap is less than US$100m (NT$643.2m market cap, or US$20.1m).お知らせ • Mar 09EBM Technologies Incorporated, Annual General Meeting, Jun 25, 2026EBM Technologies Incorporated, Annual General Meeting, Jun 25, 2026. Location: 5 floor no,516, sec.1 nei hu rd., taipei city TaiwanReported Earnings • Nov 06Third quarter 2025 earnings released: EPS: NT$0.82 (vs NT$0.28 loss in 3Q 2024)Third quarter 2025 results: EPS: NT$0.82 (up from NT$0.28 loss in 3Q 2024). Revenue: NT$113.6m (up 136% from 3Q 2024). Net income: NT$26.4m (up NT$35.3m from 3Q 2024). Profit margin: 23% (up from net loss in 3Q 2024). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 49% per year but the company’s share price has only increased by 8% per year, which means it is significantly lagging earnings growth.Buy Or Sell Opportunity • Nov 06Now 22% undervaluedOver the last 90 days, the stock has risen 4.1% to NT$22.90. The fair value is estimated to be NT$29.43, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 8.0% over the last 3 years. Meanwhile, the company has become profitable.Reported Earnings • Aug 06Second quarter 2025 earnings released: NT$0.62 loss per share (vs NT$0.99 loss in 2Q 2024)Second quarter 2025 results: NT$0.62 loss per share (improved from NT$0.99 loss in 2Q 2024). Revenue: NT$33.5m (up 20% from 2Q 2024). Net loss: NT$19.9m (loss narrowed 37% from 2Q 2024). Over the last 3 years on average, earnings per share has fallen by 8% per year but the company’s share price has increased by 2% per year, which means it is well ahead of earnings.Reported Earnings • May 09First quarter 2025 earnings released: NT$0.78 loss per share (vs NT$0.69 loss in 1Q 2024)First quarter 2025 results: NT$0.78 loss per share (further deteriorated from NT$0.69 loss in 1Q 2024). Revenue: NT$23.3m (down 14% from 1Q 2024). Net loss: NT$25.0m (loss widened 14% from 1Q 2024). Over the last 3 years on average, earnings per share has fallen by 47% per year but the company’s share price has only fallen by 1% per year, which means it has not declined as severely as earnings.Reported Earnings • Mar 19Full year 2024 earnings released: EPS: NT$0.07 (vs NT$0.44 loss in FY 2023)Full year 2024 results: EPS: NT$0.07 (up from NT$0.44 loss in FY 2023). Revenue: NT$281.0m (up 36% from FY 2023). Net income: NT$2.14m (up NT$16.1m from FY 2023). Profit margin: 0.8% (up from net loss in FY 2023). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 43% per year but the company’s share price has increased by 15% per year, which means it is well ahead of earnings.お知らせ • Mar 07EBM Technologies Incorporated, Annual General Meeting, Jun 18, 2025EBM Technologies Incorporated, Annual General Meeting, Jun 18, 2025. Location: 5 floor no,516, sec.1 nei hu rd., taipei city TaiwanReported Earnings • Nov 12Third quarter 2024 earnings released: NT$0.28 loss per share (vs NT$0.43 loss in 3Q 2023)Third quarter 2024 results: NT$0.28 loss per share (improved from NT$0.43 loss in 3Q 2023). Revenue: NT$48.2m (up 11% from 3Q 2023). Net loss: NT$8.91m (loss narrowed 35% from 3Q 2023). Over the last 3 years on average, earnings per share has fallen by 41% per year but the company’s share price has increased by 13% per year, which means it is well ahead of earnings.New Risk • Aug 18New major risk - Revenue and earnings growthEarnings have declined by 2.0% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 2.0% per year over the past 5 years. Minor Risk Market cap is less than US$100m (NT$643.2m market cap, or US$20.0m).Reported Earnings • Aug 18Second quarter 2024 earnings released: NT$0.99 loss per share (vs NT$0.46 loss in 2Q 2023)Second quarter 2024 results: NT$0.99 loss per share (further deteriorated from NT$0.46 loss in 2Q 2023). Revenue: NT$27.8m (down 18% from 2Q 2023). Net loss: NT$31.7m (loss widened 114% from 2Q 2023). Over the last 3 years on average, earnings per share has fallen by 26% per year but the company’s share price has increased by 6% per year, which means it is well ahead of earnings.Reported Earnings • May 19First quarter 2024 earnings released: NT$0.69 loss per share (vs NT$0.57 loss in 1Q 2023)First quarter 2024 results: NT$0.69 loss per share (further deteriorated from NT$0.57 loss in 1Q 2023). Revenue: NT$26.9m (down 14% from 1Q 2023). Net loss: NT$21.9m (loss widened 21% from 1Q 2023). Over the last 3 years on average, earnings per share has fallen by 1% per year but the company’s share price has increased by 7% per year, which means it is well ahead of earnings.お知らせ • Mar 23EBM Technologies Incorporated, Annual General Meeting, Jun 20, 2024EBM Technologies Incorporated, Annual General Meeting, Jun 20, 2024.Reported Earnings • Mar 23Full year 2023 earnings released: NT$0.44 loss per share (vs NT$0.13 profit in FY 2022)Full year 2023 results: NT$0.44 loss per share (down from NT$0.13 profit in FY 2022). Revenue: NT$206.1m (down 46% from FY 2022). Net loss: NT$14.0m (down 450% from profit in FY 2022). Over the last 3 years on average, earnings per share has increased by 10% per year whereas the company’s share price has increased by 7% per year.Reported Earnings • Nov 08Third quarter 2023 earnings released: NT$0.43 loss per share (vs NT$0.40 loss in 3Q 2022)Third quarter 2023 results: NT$0.43 loss per share (further deteriorated from NT$0.40 loss in 3Q 2022). Revenue: NT$43.5m (up 9.7% from 3Q 2022). Net loss: NT$13.7m (loss widened 6.8% from 3Q 2022). Over the last 3 years on average, earnings per share has increased by 11% per year whereas the company’s share price has increased by 13% per year.Reported Earnings • Aug 12Second quarter 2023 earnings released: NT$0.46 loss per share (vs NT$0.69 loss in 2Q 2022)Second quarter 2023 results: NT$0.46 loss per share (improved from NT$0.69 loss in 2Q 2022). Revenue: NT$34.0m (down 1.1% from 2Q 2022). Net loss: NT$14.9m (loss narrowed 32% from 2Q 2022). Over the last 3 years on average, earnings per share has increased by 33% per year but the company’s share price has only increased by 11% per year, which means it is significantly lagging earnings growth.Reported Earnings • Mar 29Full year 2022 earnings released: EPS: NT$0.13 (vs NT$0.73 loss in FY 2021)Full year 2022 results: EPS: NT$0.13 (up from NT$0.73 loss in FY 2021). Revenue: NT$383.9m (up 97% from FY 2021). Net income: NT$4.00m (up NT$25.9m from FY 2021). Profit margin: 1.0% (up from net loss in FY 2021). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 64% per year but the company’s share price has only increased by 15% per year, which means it is significantly lagging earnings growth.Board Change • Nov 16No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. No highly experienced directors. No independent directors (4 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.Reported Earnings • Nov 10Third quarter 2022 earnings released: NT$0.40 loss per share (vs NT$0.30 loss in 3Q 2021)Third quarter 2022 results: NT$0.40 loss per share (further deteriorated from NT$0.30 loss in 3Q 2021). Revenue: NT$39.6m (down 16% from 3Q 2021). Net loss: NT$12.9m (loss widened 38% from 3Q 2021). Over the last 3 years on average, earnings per share has increased by 51% per year but the company’s share price has only increased by 7% per year, which means it is significantly lagging earnings growth.Valuation Update With 7 Day Price Move • Sep 28Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to NT$17.55, the stock trades at a trailing P/E ratio of 31.2x. Average trailing P/E is 34x in the Healthcare Services industry in Asia. Total returns to shareholders of 23% over the past three years.Reported Earnings • Aug 15Second quarter 2022 earnings released: NT$0.68 loss per share (vs NT$0.65 loss in 2Q 2021)Second quarter 2022 results: NT$0.68 loss per share (down from NT$0.65 loss in 2Q 2021). Revenue: NT$34.4m (up 2.4% from 2Q 2021). Net loss: NT$21.9m (loss widened 21% from 2Q 2021). Over the last 3 years on average, earnings per share has increased by 29% per year but the company’s share price has only increased by 8% per year, which means it is significantly lagging earnings growth.Reported Earnings • May 14First quarter 2022 earnings released: EPS: NT$0.86 (vs NT$0.57 loss in 1Q 2021)First quarter 2022 results: EPS: NT$0.86 (up from NT$0.57 loss in 1Q 2021). Revenue: NT$212.1m (up NT$184.2m from 1Q 2021). Net income: NT$27.6m (up NT$43.7m from 1Q 2021). Profit margin: 13% (up from net loss in 1Q 2021). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 5% per year whereas the company’s share price has increased by 9% per year.Board Change • Apr 27No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. No highly experienced directors. No independent directors (4 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.Reported Earnings • Nov 13Third quarter 2021 earnings released: NT$0.30 loss per share (vs NT$0.27 loss in 3Q 2020)The company reported a soft third quarter result with increased losses and weaker control over costs, although revenues improved. Third quarter 2021 results: Revenue: NT$47.3m (up 9.9% from 3Q 2020). Net loss: NT$9.32m (loss widened 22% from 3Q 2020). Over the last 3 years on average, earnings per share has fallen by 21% per year but the company’s share price has increased by 1% per year, which means it is well ahead of earnings.Reported Earnings • May 12First quarter 2021 earnings released: NT$0.57 loss per share (vs NT$0.44 loss in 1Q 2020)The company reported a poor first quarter result with increased losses, weaker revenues and weaker control over costs. First quarter 2021 results: Revenue: NT$27.8m (down 57% from 1Q 2020). Net loss: NT$16.1m (loss widened 30% from 1Q 2020). Over the last 3 years on average, earnings per share has fallen by 4% per year whereas the company’s share price has increased by 1% per year.分析記事 • Mar 26Is EBM Technologies (GTSM:8409) Weighed On By Its Debt Load?Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...お知らせ • Mar 19EBM Technologies Incorporated, Annual General Meeting, Jun 24, 2021EBM Technologies Incorporated, Annual General Meeting, Jun 24, 2021.Reported Earnings • Mar 18Full year 2020 earnings released: NT$1.08 loss per share (vs NT$0.51 loss in FY 2019)The company reported a poor full year result with increased losses, weaker revenues and weaker control over costs. Full year 2020 results: Revenue: NT$215.3m (down 8.2% from FY 2019). Net loss: NT$30.2m (loss widened 110% from FY 2019). Over the last 3 years on average, earnings per share has increased by 15% per year but the company’s share price has fallen by 4% per year, which means it is significantly lagging earnings.Is New 90 Day High Low • Jan 07New 90-day high: NT$20.60The company is up 11% from its price of NT$18.50 on 08 October 2020. The Taiwanese market is up 16% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Healthcare Services industry, which is up 19% over the same period.分析記事 • Nov 18Is EBM Technologies (GTSM:8409) Using Debt In A Risky Way?Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...Reported Earnings • Nov 14Third quarter 2020 earnings released: NT$0.27 loss per shareThe company reported a solid third quarter result with reduced losses and improved revenues and control over expenses. Third quarter 2020 results: Revenue: NT$43.0m (up 34% from 3Q 2019). Net loss: NT$7.61m (loss narrowed 68% from 3Q 2019). Over the last 3 years on average, earnings per share has increased by 30% per year but the company’s share price has only increased by 6% per year, which means it is significantly lagging earnings growth.Is New 90 Day High Low • Nov 06New 90-day low: NT$17.75The company is down 11% from its price of NT$19.95 on 07 August 2020. The Taiwanese market is up 1.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Healthcare Services industry, which is up 10.0% over the same period.Is New 90 Day High Low • Sep 25New 90-day low: NT$18.00The company is down 16% from its price of NT$21.40 on 24 June 2020. The Taiwanese market is up 5.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Healthcare Services industry, which is up 3.0% over the same period. このセクションでは通常、投資家が会社の利益創出能力を理解する一助となるよう、プロのアナリストのコンセンサス予想に基づく収益と利益の成長予測を提示する。しかし、EBM Technologies は十分な過去のデータを提供しておらず、アナリストの予測もないため、過去のデータを外挿したり、アナリストの予測を使用しても、その将来の収益を確実に算出することはできません。 シンプリー・ウォール・ストリートがカバーする企業の97%は過去の財務データを持っているため、これはかなり稀な状況です。 業績と収益の成長予測TPEX:8409 - アナリストの将来予測と過去の財務データ ( )TWD Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数3/31/202628131-18-16N/A12/31/20252538-75-73N/A9/30/2025348462325N/A6/30/2025283114042N/A3/31/2025277-17578N/A12/31/20242812119122N/A9/30/2024200-3057N/A6/30/2024196-35-17-15N/A3/31/2024202-18-21-19N/A12/31/2023206-14-12-10N/A9/30/2023207-36-22-19N/A6/30/2023203-35-46-43N/A3/31/2023203-422228N/A12/31/202238441020N/A9/30/2022372142131N/A6/30/2022380184454N/A3/31/202237922-29-22N/A12/31/2021195-22-30-19N/A9/30/2021186-26-36-25N/A6/30/2021181-24-35-24N/A3/31/2021178-34-39-26N/A12/31/2020215-30-10-6N/A9/30/2020248-20-41N/A6/30/2020237-36-14N/A3/31/2020253-164246N/A12/31/2019235-14N/A29N/A9/30/2019221-15N/A16N/A6/30/2019225-10N/A0N/A3/31/2019220-14N/A-21N/A12/31/2018211-10N/A-39N/A9/30/2018182-31N/A-39N/A6/30/2018190-28N/A-43N/A3/31/2018190-36N/A-35N/A12/31/2017201-42N/A-16N/A9/30/2017243-44N/A-9N/A6/30/2017260-41N/A10N/A3/31/2017275-47N/A-7N/A12/31/2016255-61N/A-6N/A9/30/2016274-21N/A-9N/A6/30/2016283-19N/A0N/A3/31/2016297-6N/A-3N/A12/31/2015296-6N/A8N/A9/30/2015270-28N/A-8N/A6/30/2015242-50N/A-22N/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: 8409の予測収益成長が 貯蓄率 ( 1.3% ) を上回っているかどうかを判断するにはデータが不十分です。収益対市場: 8409の収益がTW市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です高成長収益: 8409の収益が今後 3 年間で 大幅に 増加すると予想されるかどうかを判断するにはデータが不十分です。収益対市場: 8409の収益がTW市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。高い収益成長: 8409の収益が年間20%よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。一株当たり利益成長率予想将来の株主資本利益率将来のROE: 8409の 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です成長企業の発掘7D1Y7D1Y7D1YHealthcare 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/23 16:13終値2026/05/22 00:00収益2026/03/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋EBM Technologies Incorporated 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。2 アナリスト機関Hsiu Chi LinMasterlink Securities Investment AdvisoryJianfa WeiYuanta Research
Reported Earnings • May 12First quarter 2026 earnings releasedFirst quarter 2026 results: Revenue: NT$51.6m (up 122% from 1Q 2025). Net loss: NT$1.53m (loss narrowed 94% from 1Q 2025). Over the last 3 years on average, earnings per share has increased by 105% per year but the company’s share price has fallen by 5% per year, which means it is significantly lagging earnings.
Reported Earnings • Mar 13Full year 2025 earnings released: EPS: NT$0.24 (vs NT$0.067 in FY 2024)Full year 2025 results: EPS: NT$0.24 (up from NT$0.067 in FY 2024). Revenue: NT$253.1m (down 9.9% from FY 2024). Net income: NT$7.80m (up 264% from FY 2024). Profit margin: 3.1% (up from 0.8% in FY 2024). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 78% per year but the company’s share price has remained flat, which means it is significantly lagging earnings.
New Risk • Mar 13New major risk - Earnings qualityThe company has a high level of non-cash earnings. Accrual ratio: 41% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (41% accrual ratio). Minor Risk Market cap is less than US$100m (NT$643.2m market cap, or US$20.1m).
お知らせ • Mar 09EBM Technologies Incorporated, Annual General Meeting, Jun 25, 2026EBM Technologies Incorporated, Annual General Meeting, Jun 25, 2026. Location: 5 floor no,516, sec.1 nei hu rd., taipei city Taiwan
Reported Earnings • Nov 06Third quarter 2025 earnings released: EPS: NT$0.82 (vs NT$0.28 loss in 3Q 2024)Third quarter 2025 results: EPS: NT$0.82 (up from NT$0.28 loss in 3Q 2024). Revenue: NT$113.6m (up 136% from 3Q 2024). Net income: NT$26.4m (up NT$35.3m from 3Q 2024). Profit margin: 23% (up from net loss in 3Q 2024). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 49% per year but the company’s share price has only increased by 8% per year, which means it is significantly lagging earnings growth.
Buy Or Sell Opportunity • Nov 06Now 22% undervaluedOver the last 90 days, the stock has risen 4.1% to NT$22.90. The fair value is estimated to be NT$29.43, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 8.0% over the last 3 years. Meanwhile, the company has become profitable.
Reported Earnings • Aug 06Second quarter 2025 earnings released: NT$0.62 loss per share (vs NT$0.99 loss in 2Q 2024)Second quarter 2025 results: NT$0.62 loss per share (improved from NT$0.99 loss in 2Q 2024). Revenue: NT$33.5m (up 20% from 2Q 2024). Net loss: NT$19.9m (loss narrowed 37% from 2Q 2024). Over the last 3 years on average, earnings per share has fallen by 8% per year but the company’s share price has increased by 2% per year, which means it is well ahead of earnings.
Reported Earnings • May 09First quarter 2025 earnings released: NT$0.78 loss per share (vs NT$0.69 loss in 1Q 2024)First quarter 2025 results: NT$0.78 loss per share (further deteriorated from NT$0.69 loss in 1Q 2024). Revenue: NT$23.3m (down 14% from 1Q 2024). Net loss: NT$25.0m (loss widened 14% from 1Q 2024). Over the last 3 years on average, earnings per share has fallen by 47% per year but the company’s share price has only fallen by 1% per year, which means it has not declined as severely as earnings.
Reported Earnings • Mar 19Full year 2024 earnings released: EPS: NT$0.07 (vs NT$0.44 loss in FY 2023)Full year 2024 results: EPS: NT$0.07 (up from NT$0.44 loss in FY 2023). Revenue: NT$281.0m (up 36% from FY 2023). Net income: NT$2.14m (up NT$16.1m from FY 2023). Profit margin: 0.8% (up from net loss in FY 2023). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 43% per year but the company’s share price has increased by 15% per year, which means it is well ahead of earnings.
お知らせ • Mar 07EBM Technologies Incorporated, Annual General Meeting, Jun 18, 2025EBM Technologies Incorporated, Annual General Meeting, Jun 18, 2025. Location: 5 floor no,516, sec.1 nei hu rd., taipei city Taiwan
Reported Earnings • Nov 12Third quarter 2024 earnings released: NT$0.28 loss per share (vs NT$0.43 loss in 3Q 2023)Third quarter 2024 results: NT$0.28 loss per share (improved from NT$0.43 loss in 3Q 2023). Revenue: NT$48.2m (up 11% from 3Q 2023). Net loss: NT$8.91m (loss narrowed 35% from 3Q 2023). Over the last 3 years on average, earnings per share has fallen by 41% per year but the company’s share price has increased by 13% per year, which means it is well ahead of earnings.
New Risk • Aug 18New major risk - Revenue and earnings growthEarnings have declined by 2.0% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 2.0% per year over the past 5 years. Minor Risk Market cap is less than US$100m (NT$643.2m market cap, or US$20.0m).
Reported Earnings • Aug 18Second quarter 2024 earnings released: NT$0.99 loss per share (vs NT$0.46 loss in 2Q 2023)Second quarter 2024 results: NT$0.99 loss per share (further deteriorated from NT$0.46 loss in 2Q 2023). Revenue: NT$27.8m (down 18% from 2Q 2023). Net loss: NT$31.7m (loss widened 114% from 2Q 2023). Over the last 3 years on average, earnings per share has fallen by 26% per year but the company’s share price has increased by 6% per year, which means it is well ahead of earnings.
Reported Earnings • May 19First quarter 2024 earnings released: NT$0.69 loss per share (vs NT$0.57 loss in 1Q 2023)First quarter 2024 results: NT$0.69 loss per share (further deteriorated from NT$0.57 loss in 1Q 2023). Revenue: NT$26.9m (down 14% from 1Q 2023). Net loss: NT$21.9m (loss widened 21% from 1Q 2023). Over the last 3 years on average, earnings per share has fallen by 1% per year but the company’s share price has increased by 7% per year, which means it is well ahead of earnings.
お知らせ • Mar 23EBM Technologies Incorporated, Annual General Meeting, Jun 20, 2024EBM Technologies Incorporated, Annual General Meeting, Jun 20, 2024.
Reported Earnings • Mar 23Full year 2023 earnings released: NT$0.44 loss per share (vs NT$0.13 profit in FY 2022)Full year 2023 results: NT$0.44 loss per share (down from NT$0.13 profit in FY 2022). Revenue: NT$206.1m (down 46% from FY 2022). Net loss: NT$14.0m (down 450% from profit in FY 2022). Over the last 3 years on average, earnings per share has increased by 10% per year whereas the company’s share price has increased by 7% per year.
Reported Earnings • Nov 08Third quarter 2023 earnings released: NT$0.43 loss per share (vs NT$0.40 loss in 3Q 2022)Third quarter 2023 results: NT$0.43 loss per share (further deteriorated from NT$0.40 loss in 3Q 2022). Revenue: NT$43.5m (up 9.7% from 3Q 2022). Net loss: NT$13.7m (loss widened 6.8% from 3Q 2022). Over the last 3 years on average, earnings per share has increased by 11% per year whereas the company’s share price has increased by 13% per year.
Reported Earnings • Aug 12Second quarter 2023 earnings released: NT$0.46 loss per share (vs NT$0.69 loss in 2Q 2022)Second quarter 2023 results: NT$0.46 loss per share (improved from NT$0.69 loss in 2Q 2022). Revenue: NT$34.0m (down 1.1% from 2Q 2022). Net loss: NT$14.9m (loss narrowed 32% from 2Q 2022). Over the last 3 years on average, earnings per share has increased by 33% per year but the company’s share price has only increased by 11% per year, which means it is significantly lagging earnings growth.
Reported Earnings • Mar 29Full year 2022 earnings released: EPS: NT$0.13 (vs NT$0.73 loss in FY 2021)Full year 2022 results: EPS: NT$0.13 (up from NT$0.73 loss in FY 2021). Revenue: NT$383.9m (up 97% from FY 2021). Net income: NT$4.00m (up NT$25.9m from FY 2021). Profit margin: 1.0% (up from net loss in FY 2021). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 64% per year but the company’s share price has only increased by 15% per year, which means it is significantly lagging earnings growth.
Board Change • Nov 16No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. No highly experienced directors. No independent directors (4 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
Reported Earnings • Nov 10Third quarter 2022 earnings released: NT$0.40 loss per share (vs NT$0.30 loss in 3Q 2021)Third quarter 2022 results: NT$0.40 loss per share (further deteriorated from NT$0.30 loss in 3Q 2021). Revenue: NT$39.6m (down 16% from 3Q 2021). Net loss: NT$12.9m (loss widened 38% from 3Q 2021). Over the last 3 years on average, earnings per share has increased by 51% per year but the company’s share price has only increased by 7% per year, which means it is significantly lagging earnings growth.
Valuation Update With 7 Day Price Move • Sep 28Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to NT$17.55, the stock trades at a trailing P/E ratio of 31.2x. Average trailing P/E is 34x in the Healthcare Services industry in Asia. Total returns to shareholders of 23% over the past three years.
Reported Earnings • Aug 15Second quarter 2022 earnings released: NT$0.68 loss per share (vs NT$0.65 loss in 2Q 2021)Second quarter 2022 results: NT$0.68 loss per share (down from NT$0.65 loss in 2Q 2021). Revenue: NT$34.4m (up 2.4% from 2Q 2021). Net loss: NT$21.9m (loss widened 21% from 2Q 2021). Over the last 3 years on average, earnings per share has increased by 29% per year but the company’s share price has only increased by 8% per year, which means it is significantly lagging earnings growth.
Reported Earnings • May 14First quarter 2022 earnings released: EPS: NT$0.86 (vs NT$0.57 loss in 1Q 2021)First quarter 2022 results: EPS: NT$0.86 (up from NT$0.57 loss in 1Q 2021). Revenue: NT$212.1m (up NT$184.2m from 1Q 2021). Net income: NT$27.6m (up NT$43.7m from 1Q 2021). Profit margin: 13% (up from net loss in 1Q 2021). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 5% per year whereas the company’s share price has increased by 9% per year.
Board Change • Apr 27No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. No highly experienced directors. No independent directors (4 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
Reported Earnings • Nov 13Third quarter 2021 earnings released: NT$0.30 loss per share (vs NT$0.27 loss in 3Q 2020)The company reported a soft third quarter result with increased losses and weaker control over costs, although revenues improved. Third quarter 2021 results: Revenue: NT$47.3m (up 9.9% from 3Q 2020). Net loss: NT$9.32m (loss widened 22% from 3Q 2020). Over the last 3 years on average, earnings per share has fallen by 21% per year but the company’s share price has increased by 1% per year, which means it is well ahead of earnings.
Reported Earnings • May 12First quarter 2021 earnings released: NT$0.57 loss per share (vs NT$0.44 loss in 1Q 2020)The company reported a poor first quarter result with increased losses, weaker revenues and weaker control over costs. First quarter 2021 results: Revenue: NT$27.8m (down 57% from 1Q 2020). Net loss: NT$16.1m (loss widened 30% from 1Q 2020). Over the last 3 years on average, earnings per share has fallen by 4% per year whereas the company’s share price has increased by 1% per year.
分析記事 • Mar 26Is EBM Technologies (GTSM:8409) Weighed On By Its Debt Load?Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
お知らせ • Mar 19EBM Technologies Incorporated, Annual General Meeting, Jun 24, 2021EBM Technologies Incorporated, Annual General Meeting, Jun 24, 2021.
Reported Earnings • Mar 18Full year 2020 earnings released: NT$1.08 loss per share (vs NT$0.51 loss in FY 2019)The company reported a poor full year result with increased losses, weaker revenues and weaker control over costs. Full year 2020 results: Revenue: NT$215.3m (down 8.2% from FY 2019). Net loss: NT$30.2m (loss widened 110% from FY 2019). Over the last 3 years on average, earnings per share has increased by 15% per year but the company’s share price has fallen by 4% per year, which means it is significantly lagging earnings.
Is New 90 Day High Low • Jan 07New 90-day high: NT$20.60The company is up 11% from its price of NT$18.50 on 08 October 2020. The Taiwanese market is up 16% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Healthcare Services industry, which is up 19% over the same period.
分析記事 • Nov 18Is EBM Technologies (GTSM:8409) Using Debt In A Risky Way?Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...
Reported Earnings • Nov 14Third quarter 2020 earnings released: NT$0.27 loss per shareThe company reported a solid third quarter result with reduced losses and improved revenues and control over expenses. Third quarter 2020 results: Revenue: NT$43.0m (up 34% from 3Q 2019). Net loss: NT$7.61m (loss narrowed 68% from 3Q 2019). Over the last 3 years on average, earnings per share has increased by 30% per year but the company’s share price has only increased by 6% per year, which means it is significantly lagging earnings growth.
Is New 90 Day High Low • Nov 06New 90-day low: NT$17.75The company is down 11% from its price of NT$19.95 on 07 August 2020. The Taiwanese market is up 1.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Healthcare Services industry, which is up 10.0% over the same period.
Is New 90 Day High Low • Sep 25New 90-day low: NT$18.00The company is down 16% from its price of NT$21.40 on 24 June 2020. The Taiwanese market is up 5.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Healthcare Services industry, which is up 3.0% over the same period.